G. Güner Et Al. , "Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?," Journal of Cancer Research and Clinical Oncology , vol.149, no.14, pp.13271-13277, 2023
Güner, G. Et Al. 2023. Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?. Journal of Cancer Research and Clinical Oncology , vol.149, no.14 , 13271-13277.
Güner, G., Aktaş, B. Y., Başal, F. B., DEMİRKAZIK, A., Gürsoy, P., Demirci, U., ... ERMAN, M.(2023). Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?. Journal of Cancer Research and Clinical Oncology , vol.149, no.14, 13271-13277.
Güner, Gürkan Et Al. "Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?," Journal of Cancer Research and Clinical Oncology , vol.149, no.14, 13271-13277, 2023
Güner, Gürkan Et Al. "Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?." Journal of Cancer Research and Clinical Oncology , vol.149, no.14, pp.13271-13277, 2023
Güner, G. Et Al. (2023) . "Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?." Journal of Cancer Research and Clinical Oncology , vol.149, no.14, pp.13271-13277.
@article{article, author={Gürkan Güner Et Al. }, title={Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?}, journal={Journal of Cancer Research and Clinical Oncology}, year=2023, pages={13271-13277} }